Mark Thierer - DENTSPLY SIRONA Insider

XRAY -- USA Stock  

USD 45.34  0.62  1.39%

Interim CEO
Mr. Mark Alan Thierer is no longer Interim Chief Executive Officer of the Company effective February 12, 2018. He has more than 30 years of experience in the healthcare industry. Mr. Thierer most recently served as CEO of OptumRx and oversaw all Optum pharmacy care services, including the management of pharmacy benefits, pharmacy network, home delivery pharmacy and specialty pharmacy programs. Prior to this role, Mr. Thierer served as chairman of the board and CEO of Catamaran, which was one of the nations largest pharmacy benefit management companies and merged with OptumRx in 2015. Earlier in his career, Mr. Thierer served as president, CEO and Chairman of SXC Health Solutions, which merged with Catalyst Health Solutions to create Catamaran. During his time as CEO of SXC Health Solutions, the Company posted a compound annual growth rate of 50 percent and had a 50fold increase in shareholder value
Age: 56  CEO Since 2017      
717-845-7511  http://www.dentsplysirona.com
Thierer earned a BS degree in finance from the University of Minnesota and a Master?s in Business Administration from Nova Southeastern University.

Mark Thierer Latest Insider Activity

Management Efficiency

The company has return on total asset (ROA) of 2.88 % which means that it generated profit of $2.88 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (20.57) % meaning that it created substantial loss on money invested by shareholders.
The company currently holds 1.67 B in liabilities with Debt to Equity (D/E) ratio of 24.8 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. DENTSPLY SIRONA has Current Ratio of 2.19 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.

Similar Executives

Found 11 records

CEO Since

John RatliffLaboratory Corporation of Ameri
N/A
Yue DengChina Cord Blood Corporation
N/A
Deborah TannerLaboratory Corporation of Ameri
2015
David CordaniCigna Corporation
2009
Thomas PikeIQVIA Holdings
2016
Gary HuffLaboratory Corporation of Ameri
2017
Rui ArashiyamaChina Cord Blood Corporation
N/A
Michael McMullenAgilent Technologies
2015
Ting ZhengChina Cord Blood Corporation
2017
James BoyleLaboratory Corporation of Ameri
N/A
Dow WilsonVarian Medical Systems
2012

Entity Summary

DENTSPLY SIRONA Inc. designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. DENTSPLY SIRONA Inc. was founded in 1899 and is headquartered in York, Pennsylvania. DENTSPLY SIRONA operates under Medical Instruments Supplies classification in USA and traded on NASDAQ. It employs 16100 people.DENTSPLY SIRONA (XRAY) is traded on NASDAQ in USA. It is located in 221 West Philadelphia Street and employs 16,100 people.

DENTSPLY SIRONA Leadership Team

Maureen MacInnis, President, MBA
Thomas Jetter, Director, Ph.D
Ulrich Michel, President
Rainer Berthan, President
Paula Cholmondeley, Director
John Sweeney, President
Francis Lunger, Director
Robert Size, SVP, MBA
Christopher Clark, CFO, MBA
Harry Kraemer, Director
Deborah Rasin, President
Michael Coleman, Director
Betsy Holden, Director
David Beecken, Director
Leslie Varon, Director
Eric Brandt, Director
Donald Casey, CEO, MBA
Derek Leckow, VP
Willie Deese, Director
Nicholas Alexos, President, MBA
Justin McCarthy, Executive
Albert Sterkenburg, President, Ph.D
Keith Ebling, President, MBA
John Miles, Director
William Hecht, Director
Michael Alfano, Director, Ph.D
James Mosch, COO, MBA
Jonathan Friedman, President
Mark Thierer, CEO
John Miclot, Director
Bret Wise, Chairman
Arthur Kowaloff, Director
Jeffrey Slovin, CEO, MBA

Stock Performance Indicators

Current Sentiment - XRAY

DENTSPLY SIRONA Investor Sentiment
Most of Macroaxis users are at this time bullish on DENTSPLY SIRONA. What is your opinion about investing in DENTSPLY SIRONA? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish
Skip

Also Currentnly Active

Purchased over 40 shares of
few hours ago
Traded for 67.0
Purchased over 100 shares of
few hours ago
Traded for 23.2
Purchased few shares of
few hours ago
Traded for 1188.8199
See also Your Current Watchlist. Please also try Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.